Biologics and Biomanufacturing program

NRC works with Canadian and international clients to develop biologics (large molecule medicines) to treat cancer as well as infectious, inflammatory and autoimmune diseases. With its collaborators, NRC is accelerating biologics development and manufacturing up to early clinical trials, reducing risk and adding value for each product.


If you're interested in developing biologics, optimizing your biomanufactuing processes, accessing our advanced scientific infrastructure, or connecting with our experts, please contact:

Lynne LeSauteur, Program Leader (acting)
Telephone: 514-283-1012

Online request form

Submit an online request for information about our programs and services.

Supplemental content

Targeted industries

Biopharmaceutical, biotechnology, biomanufacturers, contract research organizations.


"NRC has the diverse set of capabilities necessary to test and develop therapeutic proteins. They also have a very knowledgeable and professional staff. This combination makes them an ideal partner to complement our computational protein engineering capabilities."
David Tucker, COO, Zymeworks Inc.
Date modified: